ArticleCureus2024

GLI1-Altered Mesenchymal Tumor with ACTB Fusion and Somatostatin Receptor 2A (SSTR2A) Immunopositivity.

John Grove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.